|
Volume
21 Number 3
March 2019
|
|
Home
>
Publications
>
Reviews
in Neuro-Oncology >
Volume
21, Year 2019 >
Number 3, March
|
|
Contents
|
▼
|
|
Central
nervous system tumors
|
|
Gliomas
|
|
○
Diffuse
intrinsic pontine gliomas
|
|
○ High-grade
gliomas
|
|
Diffuse
astrocytic and oligodendroglial tumors
|
|
○
Glioblastoma
|
|
○
Oligodendroglioma
|
|
Other
astrocytic tumors
|
|
○
Pilocytic
astrocytoma
|
|
Other
gliomas
|
|
○
Chordoid
glioma of the third ventricle
|
|
Embryonal
tumors
|
|
○
Medulloblastoma
|
|
|
|
|
|
Fares J, Fares MY, Fares Y.
Natural
killer cells in the brain tumor microenvironment: Defining a new
era in neuro-oncology.
Surg Neurol Int. 2019 Mar
26, 2019;10:43→.
doi: 10.25259/SNI-97-2019→.
PMID: 31528381→.
Editorial. →
|
|
|
Central
nervous system tumors
|
▲
|
|
Díez Valle R, Hadjipanayis CG, Stummer W.
Established
and emerging uses of 5-ALA in the brain: an overview.
J
Neurooncol. 2019 Jan 3. 2019;141(3):487-494. doi:
10.1007/s11060-018-03087-7. _
|
|
|
|
Mirian C, Møller Pedersen M, Sabers A, Mathiesen T.
Antiepileptic drugs as prophylaxis for de novo brain
tumour-related epilepsy after craniotomy: a systematic review and
meta-analysis of harm and benefits.
J
Neurol Neurosurg Psychiatry. 2019 Jan 23. doi:
10.1136/jnnp-2018-319609. _
|
|
|
|
Mitrasinovic S, Zhang M, Appelboom G, Sussman E, Moore JM, Hancock
SL, Adler JR, Kondziolka D, Steinberg GK, Chang SD.
Milestones
in stereotactic radiosurgery for the central nervous system.
J
Clin Neurosci. 2018 Oct 26. 2019;59:12-19. doi:
10.1016/j.jocn.2018.09.029. _
|
|
|
Gliomas
|
▲
|
|
Ma Q, Long W, Xing C, Chu J, Luo M, Wang HY, Liu Q, Wang RF.
Cancer Stem Cells and Immunosuppressive Microenvironment
in Glioma.
Front
Immunol. 2018 Dec 21;9:2924. doi:
10.3389/fimmu.2018.02924. _
|
|
|
|
Maitra S, Bhattacharya D, Das S, Bhattacharya S.
Melatonin
and its anti-glioma functions: a comprehensive review.
Rev
Neurosci. 2019 Jan 12. doi:
10.1515/revneuro-2018-0041. _
|
|
|
Diffuse
intrinsic pontine gliomas
|
|
|
Guida L, Roux FE, Massimino M, Marras CE, Sganzerla E, Giussani C.
Safety and efficacy of Endoscopic Third Ventriculostomy
in Diffuse Intrinsic Pontine Glioma related hydrocephalus: a
Systematic Review.
World
Neurosurg. 2018 Dec 30. doi:
10.1016/j.wneu.2018.12.096. _
|
|
|
High-grade
gliomas
|
|
|
Mahmoudi K, Garvey KL, Bouras A, Cramer G, Stepp H, Jesu Raj JG,
Bozec D, Busch TM, Hadjipanayis CG.
5-aminolevulinic acid
photodynamic therapy for the treatment of high-grade gliomas.
J
Neurooncol. Jan 18. 2019;141(3):595-607. doi:
10.1007/s11060-019-03103-4. _
|
|
|
|
Philbrick BD, Adamson DC.
Early clinical trials of Toca
511 and Toca FC show a promising novel treatment for recurrent
malignant glioma.
Expert
Opin Investig Drugs. 2019 Mar;28(3):207-216. doi:
10.1080/13543784.2019.1572112. _
|
|
|
|
Prelaj A, Rebuzzi SE, Grassi M, Salvati M, D'Elia A, Buttarelli F,
Ferrara C, Tomao S, Bianco V.
Non-conventional
fotemustine schedule as second-line treatment in recurrent
malignant gliomas: Survival across disease and treatment subgroup
analysis and review of the literature.
Mol
Clin Oncol. 2018 Oct 16. 2019;10(1):58-66. doi:
10.3892/mco.2018.1746. _
Refers
to:
Addeo R et al, A new schedule of fotemustine in
temozolomide-pretreated patients with relapsing glioblastoma. J
Neurooncol.
2010 Aug 10. 2011;102(3):417-24. doi: 10.1007/s11060-010-0329-z.
Dosage error in published abstract. Correction in:
J
Neurooncol.
2010 Sep 21. 2011;102(3):425.
_
|
|
|
|
Young JS, Dayani F, Morshed RA, Okada H, Aghi MK.
Immunotherapy
for High Grade Gliomas: A Clinical Update and Practical
Considerations for Neurosurgeons.
World
Neurosurg. 2019 Jan 21. doi:
10.1016/j.wneu.2018.12.222. _
|
|
|
Diffuse
astrocytic and oligodendroglial tumors
|
▲
|
|
|
Glioblastoma
|
|
|
Abi-Aad KR, Turcotte EL, Welz ME, Krishna C, Mrugala MM, Porter
AB, Vora SA, Bendok BR.
The Use of Recombinant Poliovirus
for the Treatment of Recurrent Glioblastoma Multiforme.
World
Neurosurg. 2019 Jan 23. doi:
10.1016/j.wneu.2019.01.050. _
|
|
|
|
Ahmad F, Sun Q, Patel D, Stommel JM.
Cholesterol
Metabolism: A Potential Therapeutic Target in Glioblastoma.
Cancers
(Basel). 2019 Jan 26;11(2). pii: E146. doi:
10.3390/cancers11020146. _
|
|
|
|
Buchmann N, Gempt J.
In Reply to Letter to the Editor
Regarding "Can Early O-(2-18FFluoroethyl)-l-Tyrosine
Positron Emission Tomography After the Resection of a Glioblastoma
Predict the Location of Later Tumor Recurrence?"
World
Neurosurg. 2019 Jan 17. doi:
10.1016/j.wneu.2018.12.019. _
Refers
to:
Fang X et al, Letter to the Editor Regarding “Can Early
Postoperative O-(2-18FFluoroethyl)-l-Tyrosine
Positron Emission Tomography After Resection of Glioblastoma
Predict the Location of Later Tumor Recurrence?” World
Neurosurg.
2019 Feb 26. doi: 10.1016/j.wneu.2018.10.050. _
─
In
turn refer to: Buchmann N et al, Can Early Postoperative
O-(2-18FFluoroethyl)-l-Tyrosine
Positron Emission Tomography After Resection of Glioblastoma
Predict the Location of Later Tumor Recurrence? World
Neurosurg.
2018 Sep 27. 2019;121:e467-e474. doi: 10.1016/j.wneu.2018.09.139.
_
|
|
|
|
Ciechomska IA.
The role of autophagy in cancer -
characterization of crosstalk between apoptosis and autophagy;
autophagy as a new therapeutic strategy in glioblastoma.
Postepy
Biochem. 2018 Oct 15;64(2):119-128. doi:
10.18388/pb.2018_121. _
|
|
|
|
Fang X, Kong W, Yu Z, Qiu J, Duan H.
Letter to the Editor
Regarding “Can Early Postoperative
O-(2-18FFluoroethyl)-l-Tyrosine
Positron Emission Tomography After Resection of Glioblastoma
Predict the Location of Later Tumor Recurrence?”
World
Neurosurg. 2019 Feb 26. doi:
10.1016/j.wneu.2018.10.050. _
Refers
to:
Buchmann N et al, Can Early Postoperative
O-(2-18FFluoroethyl)-l-Tyrosine
Positron Emission Tomography After Resection of Glioblastoma
Predict the Location of Later Tumor Recurrence? World
Neurosurg.
2018 Sep 27. 2019 Jan;121:e467-e474. doi:
10.1016/j.wneu.2018.09.139.
_
|
|
|
|
Geraldo LHM, Garcia C, da Fonseca ACC, Dubois LGF, de Sampaio E
Spohr TCL, Matias D, de Camargo Magalhães ES, do Amaral RF,
da Rosa BG, Grimaldi I, Leser FS, Janeiro JM, Macharia L, Wanjiru
C, Pereira CM, Moura-Neto V, Freitas C, Lima FRS.
Glioblastoma
Therapy in the Age of Molecular Medicine.
Trends
Cancer. 2018 Dec 7. 2019 Jan;5(1):46-65. doi:
10.1016/j.trecan.2018.11.002. _
|
|
|
|
Khansur E, Shah AH, Lacy K, Komotar RJ.
Novel
Immunotherapeutics for Treatment of Glioblastoma: The Last Decade
of Research.
Cancer
Invest. 2019 Jan 11:1-7. doi:
10.1080/07357907.2018.1479414. _
|
|
|
|
Tomicic MT, Christmann M.
Targeting anticancer
drug-induced senescence in glioblastoma therapy.
Oncotarget.
2018 Dec 25;9(101):37466-37467. doi: 10.18632/oncotarget.26502.
_
Refers
to:
Aasland D et al, Temozolomide Induces Senescence and Repression of
DNA Repair Pathways in Glioblastoma Cells via Activation of
ATR-CHK1, p21, and NF-κB. Cancer
Res.
2018 Oct 25. 2019;79(1):99-113. doi:
10.1158/0008-5472.CAN-18-1733.
_
|
|
|
|
van Schaijik B, Wickremesekera AC, Mantamadiotis T, Kaye AH, Tan
ST, Stylli SS, Itinteang T.
Circulating tumor stem cells
and glioblastoma: A review.
J
Clin Neurosci. 2019 Jan 6. 2019;61:5-9. doi:
10.1016/j.jocn.2018.12.019. _
|
|
|
|
Wong ET, Swanson KD.
Dexamethasone-Friend or Foe for
Patients With Glioblastoma?
JAMA
Neurol. 2019 Jan 22. doi:
10.1001/jamaneurol.2018.4530. _
|
|
|
|
Zikou A, Sioka C, Alexiou GA, Fotopoulos A, Voulgaris S,
Argyropoulou MI.
Radiation Necrosis, Pseudoprogression,
Pseudoresponse, and Tumor Recurrence: Imaging Challenges for the
Evaluation of Treated Gliomas.
Contrast
Media Mol Imaging. 2018 Dec 2;2018:6828396. doi:
10.1155/2018/6828396. _
|
|
|
Oligodendroglioma
|
|
|
Laghari AA, Khalid MU, Qadeer N, Shamim MS.
Prognostic
value of 1p/19q chromosomal codeletion in patients with
oligodendroglioma. [With a review of the literature].
J
Pak Med Assoc. 2019 Jan;69(1):132-134.
_
|
|
|
Other
astrocytic tumors
|
▲
|
|
|
Pilocytic
astrocytoma
|
|
|
Konar SK, Shukla D, Nandeesh BN, Prabhuraj AR, Devi BI.
Surgical
Management and Outcome of a Bilateral Thalamic Pilocytic
Astrocytoma: Case Report and Review of the Literature.
Pediatr
Neurosurg. 2019 Jan 24:1-4. doi: 10.1159/000495990.
_
|
|
|
Other
gliomas
|
▲
|
|
|
Chordoid
glioma of the third ventricle
|
|
|
Danilowicz K, Abbati SG, Sosa S, Witis FL, Sevlever G.
Suprasellar chordoid glioma: a report of two cases. [With
a review of the literature].
Arch
Endocrinol Metab. 2018 Dec;62(6):648-654. doi:
10.20945/2359-3997000000092. _
|
|
|
Embryonal
tumors
|
▲
|
|
|
Medulloblastoma
|
|
|
Padovani L, Horan G, Ajithkumar T.
Radiotherapy Advances
in Paediatric Medulloblastoma Treatment.
Clin
Oncol (R Coll Radiol). 2019 Jan 14.
2019;31(3):171-181. doi: 10.1016/j.clon.2019.01.001.
_
|
|
|
bottom
|
▲
|
|
|
